Drug intelligence / Profile preview

Diapulmon

Development stage
Unknown
Lead developer
Pannon
Modality
Small Molecules
Administration
Topical, Inhalation
01

Overview

Diapulmon is a topical and inhalation pharmaceutical product developed and marketed by **PannonPharma**. It is primarily indicated for the relief of symptoms associated with upper respiratory tract infections, including cough, nasal congestion, and bronchitis. The formulation typically exists as a hydrophilic ointment or inhalation drops containing a combination of active volatile substances, most notably **camphor**, **eucalyptus oil**, and **menthol**. These ingredients function as counter-irritants and mild expectorants; when applied topically to the chest or back, they provide a warming sensation and release vapors that, when inhaled, help to clear the airways and soothe respiratory irritation. The product is a well-established treatment in the Hungarian market.

Brand names
Diapulmon
Other names
Diapulmon hidrofil kenőcsDiapulmon hydrophilic ointmentDiapulmon inhalációs cseppek
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPV3 (Transient receptor potential vanilloid subtype 3)

Beyond the preview

Go deeper on Diapulmon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diapulmon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call